App-Quantinova.ai

Evaluation of the Predictive Value of the Bleeding Prediction Score “VTE‐BLEED” for Recurrent Venous Thromboembolism

F. Klok - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Warfarin

Recurrence Risk after First Symptomatic Distal versus Proximal Deep Vein Thrombosis According to Baseline Risk Factors: A Cohort Study

L. Valerio - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Genomic and Transcriptomic Association Studies Identify 17 Novel Susceptibility Loci for Venous Thromboembolism: The INVENT Consortium

S. Lindstrom - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

WITHDRAWN: Postmenopausal Hormone Use and Venous Thromboembolism Risk in a Prospective Cohort Study: Exploring Effect Modification by Genetic Risk Factors

J. Kim - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

A Novel Gain of Function Variant of Prothrombin (p.R541W) Causes Dominant Heritable Thrombosis and Is Associated with Antithrombin Resistance

V. Muczynski - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Evithrom

Type of Combined Contraceptives and the Risk of Venous Thromboembolism in Antithrombin, Protein C and Protein S Deficient Women: A Prospective Cohort Study

D. Tormene - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Protein C

Diagnosis of Pulmonary Embolism Using D‐Dimer Thresholds Selected According to Clinical Pre‐Test Probability

K. de Wit - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Predicting Venous Thromboembolism Risk after Immobilization of the Lower‐limb for Trauma: Update and Validation of a Clinical Risk Assessment Model, the TRiP(Cast) Score

D. Douillet - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Acute Submassive Pulmonary Embolism is Not Associated with an Increased Rate of Chronic Thromboembolic Pulmonary Hypertension

H. Stevens - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Association of Body Weight with Efficacy and Safety of Apixaban and Rivaroxaban in Relation to Low Molecular Heparin and Vitamin K Antagonists in Acute Venous Thromboembolism

W. Wysokinski - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

rivaroxaban

Use of Direct Oral Anticoagulants in Patients with Different Types of Hereditary Thrombophilia: A Retrospective Cohort Study

E. Campello - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

Warfarin

Thrombosis Risk after Switching Oral Contraceptive Type

D. Khialani - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Preventing Postpartum Venous Thromboembolism; Impact of Systematic VTE Risk Assessment

F. O'Shaughnessy - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Performance of Standard Dose Enoxaparin in Preventing Pregnancy‐associated Venous Thromboembolism

P. Banahene - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Enoxaparin

Application of bleeding score in children referred due to preoperative assessment

H. Pergantou - European Association for Haemophilia and Allied Disorders (EAHAD) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

FVIII

Thromboprophylaxis and surgical outcomes in people with haemophilia undergoing orthopaedic surgery: Establishing a local standard of care

Y. Seldon - European Association for Haemophilia and Allied Disorders (EAHAD) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Exposure degree to recombinant factors and bleeding episodes in patients with severe haemophilia “A” in a single haemophilia centre

L. Tomas - European Association for Haemophilia and Allied Disorders (EAHAD) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

FVIII

A 14‐year old boy with vascular Ehlers‐Danlos syndrome and left fibular artery rupture

K. Koch - European Association for Haemophilia and Allied Disorders (EAHAD) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Prothrombin complex

Long-term Outcomes After Left Main Coronary Artery Percutaneous Coronary Intervention in Patients Presenting with Acute Coronary Syndrome

Sida Jia - Angioplasty Summit-TCTAP , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Large-diameter Coronary Artery Stenting

Sergey Vladimirovich Sokolov - Angioplasty Summit-TCTAP , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Filters

7277 Abstracts